InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: TradingPro post# 349502

Sunday, 02/28/2021 10:06:03 AM

Sunday, February 28, 2021 10:06:03 AM

Post# of 403568
Possible, but I can't believe that Leo would make that mistake twice unless he was forced to do so. Maybe that is why he went to Russia. I have faith that this will turn out good for longs. We should know soon.

Go Leo & IPIX!

Or to payoff the CRO to say the SOC was the B arm for a few of the trial sites. I kinda wonder if that happened with P. As on of the large data sets from a trial site results were near identical to P but said those patients were the SOC, killing the P efficacy results. Maybe it was a mistake. In any case that may me realize that double blind trials are ripe for corruption and I don’t think they really make a difference.


Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

Brilacidin in Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating COVID-19.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News